Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Finished Goods (2009 - 2025)

Fresenius Medical Care AG (FMCQF) posted Finished Goods of $1.5 billion for Q4 2025, up 15.3% on a QoQ basis from $1.3 billion in Q4 2024, and up 15.3% year-over-year from $1.3 billion in Q4 2024.

Fresenius Medical Care AG (FMCQF) has 17 years of Finished Goods data on file, last reported at $1.5 billion in Q4 2025.

  • In Q4 2025, Finished Goods rose 15.3% year-over-year to $1.5 billion; the TTM figure through Dec 2025 stood at $1.5 billion (up 15.3% YoY), while the FY2025 annual figure was $1.5 billion, up 15.3% from the prior year.
  • Finished Goods rose to $1.5 billion in Q4 2025, from $1.3 billion in the prior quarter.
  • Across five years, Finished Goods topped out at $1.5 billion in Q4 2025 and bottomed at $1.3 billion in Q4 2024.
  • A 5-year average of $1.4 billion and a median of $1.3 billion in 2022 frame the typical range for Finished Goods.
  • Annual changes were most pronounced in 2022 — Finished Goods fell 5.19% — and 2025, when it increased 15.3%.
  • Year by year, Finished Goods stood at $1.4 billion in 2021, then slipped by 5.19% to $1.3 billion in 2022, then retreated by 0.84% to $1.3 billion in 2023, then dropped by 4.76% to $1.3 billion in 2024, then increased by 15.3% to $1.5 billion in 2025.
  • The last three Finished Goods figures came in at $1.5 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.3 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Fresenius Medical Care AG - - 22,843.10 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.46 Bn
Dec 31, 2024 1.26 Bn
Dec 31, 2023 1.33 Bn
Dec 31, 2022 1.34 Bn
Dec 31, 2021 1.41 Bn
Dec 31, 2020 1.30 Bn
Dec 31, 2019 1.04 Bn
Dec 31, 2018 883.59 Mn
Dec 31, 2017 792.24 Mn
Dec 31, 2016 742.43 Mn
Dec 31, 2015 670.29 Mn
Dec 31, 2014 677.11 Mn
Dec 31, 2013 640.36 Mn
Dec 31, 2012 627.34 Mn
Dec 31, 2011 610.57 Mn
Dec 31, 2010 475.64 Mn
Dec 31, 2009 481.05 Mn